Pluryal Contour Lidocaine 1x1ml (1x1ml)
MEDICAL USE. MEDICAL DEVICE. For successful treatment it is essential that the practitioner has received a specific training on the injection techniques for soft tissue augmentation. Pluryal Contour Lidocaine 1x1ml (1x1ml)
INSTANT SELF CONFIDENCE WITH LONG LASTING EFFECTS. Volume correction and countour shaping.
AREAS OF INJECTIONS
Aging & Volume Loss: Facial aging is associated with the loss of soft tissue fat fullness in certain area,periorbital, forehead, malar, temporal, mandibular, mental, glabellar or perioral sites and persistence of fat in others submental, lateral nasolabial folds and labiomental crease, jowls, infraorbital fat pouche, and malar fat pad).
- Correct mid-face facial volume deficit.
- Restore the facial volume.
- Shape the contours of the face.
- Address reconstructive treatments of facial lipoatrophy.
PLURYAL CONTOUR LIDOCAINE is carefully formulated to give your patients back the volume they are used to and the confidence they deserve.
WHY USE PLURYAL CONTOUR LIDOCAINE? These symptoms create an imbalance and cause a tired effect, especially in the area known as the “midface” which is important in facial aesthetics due to that fact that the perceptions of facial attractiveness are largely based on the synergy of the eyes, nose, lips and cheek bones (central facial triangle).
Periorbital, forehead, malar, temporal, mandibular, mental, glabellar, and perioral sites.
COMPOSITION PLURYAL CONTOUR LIDOCAINE
- Crosslinked hyaluronic acid 2.5% (25mg/ml) with 0.3% lidocaine 0.3% (3mg/ml)
- Crosslinking agent G’ factor BDDE ++++ 650,000 mPa
- INJECTION Deep dermis, subcutaneous or supraperiosteal.
- PACKAGING 1 x 1ml syringe
- 2 x 27G1⁄2″ ultra thin wall needles (CE 0197) by Terumo.
- PREMIUM GLASS SYRINGE FOR Innovation for safety & comfort.
- DURATION PLURYAL CONTOUR LIDOCAINE 9-12 months.
EASINESS OF USE
Low extrusion force. Thanks to an optimized production process, PLURYAL CONTOUR LIDOCAINE shows a low extrusion force compared to competitors. A low extrusion force is beneficial for smooth and predictable injections. The in vitro enzymatic degradation experiments show that PLURYAL CONTOUR LIDOCAINE is considerably more stable than competitor products. In particular the experiment portrayed slower enzymatic degradation which may predict a longer lasting effect in patients.
DECADES OF EXPERTISE IN HYALURONIC ACID
MD SKIN SOLUTIONS has partnered with CROMA-Pharma GmbH a reliable manufacturer of hyaluronic acid products for decades. Operating it a state-of-the-art facilities located next to Vienna, in Austria, Croma-Pharma GmbH has manufactured more than 50 million syringes till date.
Associating two main advantages: High shaping capacity (high G’ factor) Easiness of use (low Extrusion Force)
The formulation of PLURYAL CONTOUR LIDOCAINE combined with the new CROMA syringe allows for predictable results and a smooth injection, causing less stress to the tissue and guaranteeing both patient comfort and patient satisfaction. Pluryal Contour Lidocaine nicely integrates into the surrounding tissue while providing the ultimate structural support.
There are no reviews yet.